Intermediate-conductance Ca2+-activated K+ channels (IKCa1) regulate human prostate cancer cell proliferation through a close control of calcium entry
Tóm tắt
Từ khóa
Tài liệu tham khảo
Ayub M, Levell MJ . (1990). The inhibition of human prostatic aromatase activity by imidazole drugs including ketoconazole and 4-hydroxyandrostenedione. Biochem Pharmacol 40: 1569–1575.
Baksh S, Widlund HR, Frazer-Abel AA, Du J, Fosmire S, Fisher DE et al. (2002). NFATc2-mediated repression of cyclin-dependent kinase 4 expression. Mol Cell 10: 1071–1081.
Benito J, Martin-Castellanos C, Moreno S . (1998). Regulation of the G1 phase of the cell cycle by periodic stabilization and degradation of the p25rum1 CDK inhibitor. EMBO J 17: 482–497.
Berridge MJ, Bootman MD, Roderick HL . (2003). Calcium signalling: dynamics, homeostasis and remodelling. Nat Rev Mol Cell Biol 4: 517–529.
Bidaux G, Roudbaraki M, Merle C, Crepin A, Delcourt P, Slomianny C et al. (2005). Evidence for specific TRPM8 expression in human prostate secretory epithelial cells: functional androgen receptor requirement. Endocr Relat Cancer 12: 367–382.
Bloch M, Ousingsawat J, Simon R, Schraml P, Gasser TC, Mihatsch MJ et al. (2007). KCNMA1 gene amplification promotes tumor cell proliferation in human prostate cancer. Oncogene 26: 2525–2534.
Chittajallu R, Chen Y, Wang H, Yuan X, Ghiani CA, Heckman T et al. (2002). Regulation of Kv1 subunit expression in oligodendrocyte progenitor cells and their role in G1/S phase progression of the cell cycle. Proc Natl Acad Sci USA 99: 2350–2355.
Chomczynski P, Sacchi N . (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate–phenol–chloroform extraction. Anal Biochem 162: 156–159.
Devor DC, Singh AK, Frizzell RA, Bridges RJ . (1996). Modulation of Cl- secretion by benzimidazolones. I. Direct activation of a Ca(2+)-dependent K+ channel. Am J Physiol 271 (5 Part 1): L775–L784.
Ducret T, Boudina S, Sorin B, Vacher AM, Gourdou I, Liguoro D et al. (2002). Effects of prolactin on intracellular calcium concentration and cell proliferation in human glioma cells. Glia 38: 200–214.
Enomoto N, Kitamura T, Hirose M, Ikejima K, Watanabe S, Sato N . (1998). Differential Ca2+ signaling in neonatal and adult rat hepatocyte doublets. J Hepatol 28: 221–230.
Gackiere F, Bidaux G, Lory P, Prevarskaya N, Mariot P . (2006). A role for voltage gated T-type calcium channels in mediating ‘capacitative’ calcium entry? Cell Calcium 39: 357–366.
Ghanshani S, Wulff H, Miller MJ, Rohm H, Neben A, Gutman GA et al. (2000). Up-regulation of the IKCa1 potassium channel during T-cell activation. Molecular mechanism and functional consequences. J Biol Chem 275: 37137–37149.
Ghiani CA, Eisen AM, Yuan X, DePinho RA, McBain CJ, Gallo V . (1999). Neurotransmitter receptor activation triggers p27(Kip1 )and p21(CIP1) accumulation and G1 cell cycle arrest in oligodendrocyte progenitors. Development 126: 1077–1090.
Grigorian M, Andresen S, Tulchinsky E, Kriajevska M, Carlberg C, Kruse C et al. (2001). Tumor suppressor p53 protein is a new target for the metastasis-associated Mts1/S100A4 protein: functional consequences of their interaction. J Biol Chem 276: 22699–22708.
Gupta S, Hussain T, MacLennan GT, Fu P, Patel J, Mukhtar H . (2003). Differential expression of S100A2 and S100A4 during progression of human prostate adenocarcinoma. J Clin Oncol 21: 106–112.
Gut A, Balda MS, Matter K . (1998). The cytoplasmic domains of a beta1 integrin mediate polarization in Madin-Darby canine kidney cells by selective basolateral stabilization. J Biol Chem 273: 29381–29388.
Hazelton B, Mitchell B, Tupper J . (1979). Calcium, magnesium, and growth control in the WI-38 human fibroblast cell. J Cell Biol 83 (2 Part 1): 487–498.
Hemmerlein B, Weseloh RM, Mello de Queiroz F, Knotgen H, Sanchez A, Rubio ME et al. (2006). Overexpression of Eag1 potassium channels in clinical tumours. Mol Cancer 5: 41.
Jager H, Dreker T, Buck A, Giehl K, Gress T, Grissmer S . (2004). Blockage of intermediate-conductance Ca2+-activated K+ channels inhibit human pancreatic cancer cell growth in vitro. Mol Pharmacol 65: 630–638.
Khanna R, Chang MC, Joiner WJ, Kaczmarek LK, Schlichter LC . (1999). hSK4/hIK1, a calmodulin-binding KCa channel in human T lymphocytes. Roles in proliferation and volume regulation. J Biol Chem 274: 14838–14849.
Legrand G, Humez S, Slomianny C, Dewailly E, Vanden Abeele F, Mariot P et al. (2001). Ca2+ pools and cell growth. Evidence for sarcoendoplasmic Ca2+-ATPases 2B involvement in human prostate cancer cell growth control. J Biol Chem 276: 47608–47614.
Lehen'kyi V, Flourakis M, Skryma R, Prevarskaya N . (2007). TRPV6 channel controls prostate cancer cell proliferation via Ca(2+)/NFAT-dependent pathways. Oncogene 26: 7380–7385.
Lu X, Fein A, Feinstein MB, O′Rourke FA . (1999). Antisense knock out of the inositol 1,3,4,5-tetrakisphosphate receptor GAP1(IP4BP) in the human erythroleukemia cell line leads to the appearance of intermediate conductance K(Ca) channels that hyperpolarize the membrane and enhance calcium influx. J Gen Physiol 113: 81–96.
Magnier-Gaubil C, Herbert JM, Quarck R, Papp B, Corvazier E, Wuytack F et al. (1996). Smooth muscle cell cycle and proliferation. Relationship between calcium influx and sarco-endoplasmic reticulum Ca2+ATPase regulation. J Biol Chem 271: 27788–27794.
Mariot P, Vanoverberghe K, Lalevee N, Rossier MF, Prevarskaya N . (2002). Overexpression of an alpha 1H (Cav3.2) T-type calcium channel during neuroendocrine differentiation of human prostate cancer cells. J Biol Chem 277: 10824–10833.
Maurice M, Pichard L, Daujat M, Fabre I, Joyeux H, Domergue J et al. (1992). Effects of imidazole derivatives on cytochromes P450 from human hepatocytes in primary culture. FASEB J 6: 752–758.
Nilius B, Schwarz G, Droogmans G . (1993). Control of intracellular calcium by membrane potential in human melanoma cells. Am J Physiol 265 (6 Part 1): C1501–C1510.
Ouadid-Ahidouch H, Le Bourhis X, Roudbaraki M, Toillon RA, Delcourt P, Prevarskaya N . (2001). Changes in the K+ current-density of MCF-7 cells during progression through the cell cycle: possible involvement of a h-ether.a-gogo K+ channel. Recept Channels 7: 345–356.
Ouadid-Ahidouch H, Roudbaraki M, Ahidouch A, Delcourt P, Prevarskaya N . (2004). Cell-cycle-dependent expression of the large Ca2+-activated K+ channels in breast cancer cells. Biochem Biophys Res Commun 316: 244–251.
Pardo LA, Contreras-Jurado C, Zientkowska M, Alves F, Stuhmer W . (2005). Role of voltage-gated potassium channels in cancer. J Membr Biol 205: 115–124.
Pardo LA, del Camino D, Sanchez A, Alves F, Bruggemann A, Beckh S et al. (1999). Oncogenic potential of EAG K(+) channels. EMBO J 18: 5540–5547.
Pardo LM, van Duijn CM . (2005). In search of genes involved in neurodegenerative disorders. Mutat Res 592: 89–101.
Parihar AS, Coghlan MJ, Gopalakrishnan M, Shieh CC . (2003). Effects of intermediate-conductance Ca2+-activated K+ channel modulators on human prostate cancer cell proliferation. Eur J Pharmacol 471: 157–164.
Pedersen KA, Schroder RL, Skaaning-Jensen B, Strobaek D, Olesen SP, Christophersen P . (1999). Activation of the human intermediate-conductance Ca(2+)-activated K(+) channel by 1-ethyl-2-benzimidazolinone is strongly Ca(2+)-dependent. Biochim Biophys Acta 1420: 231–240.
Pena TL, Chen SH, Konieczny SF, Rane SG . (2000). Ras/MEK/ERK up-regulation of the fibroblast KCa channel FIK is a common mechanism for basic fibroblast growth factor and transforming growth factor-beta suppression of myogenesis. J Biol Chem 275: 13677–13682.
Peng JB, Zhuang L, Berger UV, Adam RM, Williams BJ, Brown EM et al. (2001). CaT1 expression correlates with tumor grade in prostate cancer. Biochem Biophys Res Commun 282: 729–734.
Rodrigues AD, Gibson GG, Ioannides C, Parke DV . (1987). Interactions of imidazole antifungal agents with purified cytochrome P-450 proteins. Biochem Pharmacol 36: 4277–4281.
Roudbaraki M, Lorsignol A, Langouche L, Callewaert G, Vankelecom H, Denef C . (1999). Target cells of gamma3-melanocyte-stimulating hormone detected through intracellular Ca2+ responses in immature rat pituitary constitute a fraction of all main pituitary cell types, but mostly express multiple hormone phenotypes at the messenger ribonucleic acid level. Refractoriness to melanocortin-3 receptor blockade in the lacto-somatotroph lineage. Endocrinology 140: 4874–4885.
Sherbet GV, Lakshmi MS . (1998). S100A4 (MTS1) calcium binding protein in cancer growth, invasion and metastasis. Anticancer Res 18: 2415–2421.
Si H, Grgic I, Heyken WT, Maier T, Hoyer J, Reusch HP et al. (2006). Mitogenic modulation of Ca2+-activated K+ channels in proliferating A7r5 vascular smooth muscle cells. Br J Pharmacol 148: 909–917.
Skryma R, Mariot P, Bourhis XL, Coppenolle FV, Shuba Y, Vanden Abeele F et al. (2000). Store depletion and store-operated Ca2+ current in human prostate cancer LNCaP cells: involvement in apoptosis. J Physiol 527 (Part 1): 71–83.
Skryma R, Van Coppenolle F, Dufy-Barbe L, Dufy B, Prevarskaya N . (1999). Characterization of Ca(2+)-inhibited potassium channels in the LNCaP human prostate cancer cell line. Recept Channels 6: 241–253.
Skryma RN, Prevarskaya NB, Dufy-Barbe L, Odessa MF, Audin J, Dufy B . (1997). Potassium conductance in the androgen-sensitive prostate cancer cell line, LNCaP: involvement in cell proliferation. Prostate 33: 112–122.
Spitzner M, Ousingsawat J, Scheidt K, Kunzelmann K, Schreiber R . (2007). Voltage-gated K+ channels support proliferation of colonic carcinoma cells. FASEB J 21: 35–44.
Thebault S, Flourakis M, Vanoverberghe K, Vandermoere F, Roudbaraki M, Lehen'kyi V et al. (2006). Differential role of transient receptor potential channels in Ca2+ entry and proliferation of prostate cancer epithelial cells. Cancer Res 66: 2038–2047.
Thebault S, Roudbaraki M, Sydorenko V, Shuba Y, Lemonnier L, Slomianny C et al. (2003). Alpha1-adrenergic receptors activate Ca(2+)-permeable cationic channels in prostate cancer epithelial cells. J Clin Invest 111: 1691–1701.
Tomita M, Hirata Y, Takata S, Fujita T . (1987). Effects of calcium-antagonists and calmodulin inhibitors on DNA synthesis in cultured rat vascular smooth muscle cells. Endocrinol Jpn 34: 313–318.
Tupper JT, Kaufman L, Bodine PV . (1980). Related effects of calcium and serum on the G1 phase of the human W138 fibroblast. J Cell Physiol 104: 97–103.
Turowski P, Adamson P, Sathia J, Zhang JJ, Moss SE, Aylward GW et al. (2004). Basement membrane-dependent modification of phenotype and gene expression in human retinal pigment epithelial ARPE-19 cells. Invest Ophthalmol Vis Sci 45: 2786–2794.
van de Graaf SF, Hoenderop JG, Bindels RJ . (2006). Regulation of TRPV5 and TRPV6 by associated proteins. Am J Physiol Renal Physiol 290: F1295–F1302.
Vanden Abeele F, Roudbaraki M, Shuba Y, Skryma R, Prevarskaya N . (2003). Store-operated Ca2+ current in prostate cancer epithelial cells. Role of endogenous Ca2+ transporter type 1. J Biol Chem 278: 15381–15389.
Vanoverberghe K, Mariot P, Vanden Abeele F, Delcourt P, Parys JB, Prevarskaya N . (2003). Mechanisms of ATP-induced calcium signaling and growth arrest in human prostate cancer cells. Cell Calcium 34: 75–85.
Vanoverberghe K, Vanden Abeele F, Mariot P, Lepage G, Roudbaraki M, Bonnal JL et al. (2004). Ca2+ homeostasis and apoptotic resistance of neuroendocrine-differentiated prostate cancer cells. Cell Death Differ 11: 321–330.
von Hahn T, Thiele I, Zingaro L, Hamm K, Garcia-Alzamora M, Kottgen M et al. (2001). Characterisation of the rat SK4/IK1 K(+) channel. Cell Physiol Biochem 11: 219–230.
Wang S, Melkoumian Z, Woodfork KA, Cather C, Davidson AG, Wonderlin WF et al. (1998). Evidence for an early G1 ionic event necessary for cell cycle progression and survival in the MCF-7 human breast carcinoma cell line. J Cell Physiol 176: 456–464.
Wonderlin WF, Strobl JS . (1996). Potassium channels, proliferation and G1 progression. J Membr Biol 154: 91–107.
Woolf SH . (1995). Screening for prostate cancer with prostate-specific antigen. An examination of the evidence. N Engl J Med 333: 1401–1405.